Joe joined Vericel in 2021 with more than 20 years of financial, strategic and operational experience, including more than 14 years of experience in the biotech industry. Prior to joining Vericel, Joe most recently served as Vice President, Finance and Head of Investor Relations at Biogen Inc. While at Biogen, Joe held several finance leadership roles, including Vice President, Global Financial Planning and Analysis and Strategic Corporate Finance and Vice President, U.S. Finance and Operations. Joe worked across the entire Biogen organization, in roles of increasing responsibility within Finance across R&D, Corporate Finance, Corporate Strategy and Commercial operations, supporting company strategy, business development and several commercial launches. Prior to joining Biogen, Joe held finance and strategy roles in the financial services and technology industries, including at Thomson Reuters Corporation and Fidelity Investments. Joe earned a B.A. degree in Economics and International Studies from Northwestern University and an M.B.A. from the Sloan School of Management at M.I.T.
This person is not in any offices
Vericel
Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions